Oncology Institute Inc’s filing revealed that its Chief Financial Officer Carter Robert Ross unloaded Company’s shares for reported $879.0 on Jan 02 ’26. In the deal valued at $3.56 per share,247 shares were sold. As a result of this transaction, Carter Robert Ross now holds 235,122 shares worth roughly $0.98 million.
Then, Hively Brad sold 13,333 shares, generating $50,291 in total proceeds. Upon selling the shares at $3.77, the Director now owns 683,721 shares.
Before that, BRADFORD DANIEL HIVELY bought 13,333 shares. Oncology Institute Inc shares valued at $50,291 were divested by the Director at a price of $3.77 per share.
Needham initiated its Oncology Institute Inc [TOI] rating to a Buy in a research note published on November 25, 2025; the price target was $5. A number of analysts have revised their coverage, including Noble Capital Markets’s analysts, who began to cover the stock in late July with a ‘”an Outperform”‘ rating. B. Riley Securities began covering TOI with “Buy” recommendation on July 16, 2025. BTIG Research started covering the stock on May 15, 2025. It rated TOI as “a Buy”.
Price Performance Review of TOI
On Monday, Oncology Institute Inc [NASDAQ:TOI] saw its stock fall -3.02% to $4.18. Over the last five days, the stock has gained 13.90%. Oncology Institute Inc shares have risen nearly 1198.14% since the year began. Nevertheless, the stocks have risen 17.42% over the past one year.
How much short interest is there in Oncology Institute Inc?
A steep rise in short interest was recorded in Oncology Institute Inc stocks on 2025-12-15, growing by 2.97 million shares to a total of 7.42 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 4.45 million shares. There was a rise of 40.02%, which implies that there is a positive sentiment for the stock.
